Prominent scientists in cloning
  Home Page | What is cloning | Scientists in cloning |  Development of fetus |  Benefits of human cloning |  Human cloning |  Cloning efficiency |  Stem cells | Stem cell research |  Advanced cell research |  Links |  Methods of cloning |  Abnormalities in clones |  Animals cloned |  Thylacin cloning |  Monkey cloning |  Cloning a mammoth | Photoalbum  


Ian Wilmut is the leader of the team that produced Dolly, the first animal to develop after nuclear transfer from an adult cell. The present objectives of the research group are to determine the molecular mechanisms that are important for normal development of cloned embryos and to use that knowledge in biology, medicine and agriculture. Potential applications include the derivation of human cells for therapy the provision of organs for transplantation and the cloning and modification of animals in agriculture.

Professor Wilmut was born in Hampton Lucy in Warwickshire in 1944, is married and has three children and three grandchildren. He lives in the Border countryside south of Edinburgh and enjoys walking, photography, classical music, gardening and curling.

Professor Wilmut obtained a B.Sc. in Agricultural Science at the University of Nottingham before studying with Professor "Chris" Polge FRS at the University of Cambridge. His Ph.D. degree was awarded in 1971 for research on the Deep Freeze Preservation of Boar Semen. Subsequent research in Cambridge led to the birth of the first calf from a frozen embryo - "Frosty" - in 1973.

He moved to Edinburgh in 1973. Over the past nine years, research has been focused on the factors regulating embryo development after nuclear transfer. This work led to the first birth of live lambs from embryo-derived cells and then to the birth of lambs derived from foetal and adult cells, including Dolly. Subsequently, genetic changes were introduced into sheep by nuclear transfer from cultured modified cells.

As well as being Head of a Department in Roslin Institute he also serves as Scientific Advisor of Geron Bio-Med.

His research has been recognised by the award of an OBE in the Queen's birthday honours of 1999 and election to the Fellowship of the Royal Society of Edinburgh and the Royal Society.

President and CEO of Zavos Diagnostic Laboratories, Inc., a private corporation that markets infertility products and technologies, in the USA and worldwide
Founder, Director and Chief Andrologist of the Andrology Institute of America
Founder and Executive Director of the Home Fertility Network
Co-Founder and Associate Director of the Greek-American Andrology Institute of Athens, Greece
Professor Emeritus of Reproductive Physiology-Andrology at the University of Kentucky, in Lexington, KY, USA
Honorary Professor, China Academy of Science
Greek Representative for the Initiative of the Olympia Forum, 2004


Born February 23, 1944, in Tricomo, Cyprus, Panayiotis Michael Zavos is the second youngest son of Michael and Theodora Zavos. He comes from a very successful family, holding numerous national and international companies and institutions. He grew up in Tricomo, and attended the Agricultural Gymnasium of Morphou (High school) in the city of Morphou. He worked at the Agricultural Research Institute of Cyprus and served as a Lieutenant in the Cypriot Army from 1963-1966. He immigrated to the United States for University studies in 1966.

Dr. Panayiotis Zavos received his B.S. in Biology-Chemistry in 1970, his M.S. in Biology-Physiology in 1972 and Education Specialist in Science (Ed.S.) in 1976 from Emporia State University in Emporia, Kansas. He earned his Ph.D. in Reproductive Physiology, Biochemistry and Statistics in 1978 from the University of Minnesota in the Twin Cities, Minnesota. He received the Distinguished Alumnus Award and the Graduate Teaching Award from Emporia State University and the Student Leadership Award from the University of Minnesota.

Dr. Zavos has a long career as a reproductive specialist and he has devoted more than 25 years to academia and research. He is the chief scientist in the development of several new and innovative technologies in the animal and human reproductive areas with worldwide implications. He has authored or coauthored more than 400 peer-review publications, along with a number of solicited reviews, book chapters and popular press releases. He has presented more than 300 abstracts and other presentations at a large number of national, international and professional scientific meetings all over the world. Dr. Zavos' studies and findings have been reported in the local, national and international press. He served as an ad hoc reviewer for the NIH and other scientific groups.

Dr. Zavos is currently serving as a Board Member of the Middle East Fertility Society, and is a past Board Member of the China Academy of Science. He was awarded the first ever Honorary Professorship by the Chinese Academy of Science awarded to an American by Chinese Scientists. He has given plenary lectures nationally and internationally at a number of Scientific Societies meetings, has been and continues to be a visiting scientist for a number of international collaborations and exchanges.

Dr. Zavos has numerous scientific collaborations nationally and internationally and his publications have appeared in eight languages. He is a member of the American Society for Reproductive Medicine (ASRM), the American Society of Andrology (ASA), the European Society for Human Reproduction and Embryology (ESHRE), the Middle East Fertility Society ( MEFS), the Japanese Fertility Society, the International Society of Cryobiology Sigma XI, Gamma Sigma Delta and a number of other Scientific and Professional Societies. He has served on a large number of committees for the International Society of Cryobiology, ASRM, MEFS, ESHRE and others.

Professor Zavos has received a great deal of media coverage both within the scientific and reproductive arena and the mainstream press for his many scientific accomplishments and pioneering ventures. He has made many television and radio appearances including: NPR Radio, 60 Minutes, Dateline NBC with Stone Phillips, The Connie Chung Show on CNN, Face the Nation, BBC World, ESPN, Tech TV, Nightline, Fox TV, World News Tonight, Good Morning America on ABC, The Early Show, CBS This Morning, CNN News, CNN, CNN International, Reuters, HBO, The View with Barbara Walters, National Geographic, Televisione svizzera (Swiss TV), Cyprus Broadcasting Corporation, Antena TV of Cyprus and Greece, Tokyo Broadcasting System International, NHK Television (Japan), Nippon Television of Japan, TV Asahi (Japan), ZDF TV (Germany), Deutsche Welle TV (Germany), Nine Network TV (Australia), National TV (Israel) and Live Talk with Sabine Christiansen (Germany).

Dr. Zavos is recognized worldwide as a leading researcher and a strong authority in the areas of male reproductive physiology, gamete physiology, male infertility, Andrology and other ART procedures including the development of in-vitro round spermatid manipulations (ROSI procedures). Dr. Zavos is also recognized as an international authority on smoking and its effects on human reproductive performance.

The 55-year-old Dr Antinori was previously best known for his work in in vitro fertilisation, and in particular for enabling women in their 50s and 60s to give birth.

He shot to prominence in 1994 when he helped a 63-year-old woman to have a baby by implanting a donor's fertilised egg in her uterus, making her the oldest known women in the world to give birth.

Michael D. West.
Michael D. West, Ph.D.
President and CEO,
Advanced Cell Technology

President & Chief Executive Officer - Dr. West received a B.S. degree from Rensselaer Polytechnic Institute in 1976, his M.S. in Biology from Andrews University in 1982, and his Ph.D. from Baylor College of Medicine in 1989. He has extensive academic and business experience in age-related degenerative disease, telomerase molecular biology, and human embryonic stem cells. From 1998-1999 he was a Co-founder and Chairman of Origen Therapeutics of South San Francisco, California, a company developing transgenic technology in commercial poultry. From 1990 to 1998 he was the founder, director and Vice President of Geron Corporation of Menlo Park, California, where he initiated and managed programs in telomerase diagnostics, telomerase inhibition, telomerase-mediated therapy, and human embryonic stem cel
Jose B. Cibelli
Jose B. Cibelli, D.V.M., Ph.D.
Vice President, Research
Advanced Cell Technology
Robert P. Lanza
Robert P. Lanza, M.D.
Vice President, Medical &
Scientific Development,
Advanced Cell Technology

Vice President of Medical & Scientific Development - Dr. Lanza is a former Fulbright Scholar and has been nominated for a MacArthur Foundation "genius" award. He has several hundred publications, including Principles of Tissue Engineering (Academic Press, 1st Edition, 1997; 2nd Edition, 2000), XENO: The Promise of Transplanting Animal Organs Into Humans (Oxford University Press, 2000), Yearbook of Cell and Tissue Transplantation (Kluwer Academic Publishers, 1996), One World: The Health and Survival of the Human Species in the 21st Century (as editor, with Forewords and Conclusion by C. Everett Koop, former President Jimmy Carter, and UN Secretary-General Boutros Boutros-Gahli), Pancreatic Islet Transplantation Series (Volumes I, II, III; Landes/CRC Press, 1994), Medical Science and the Advancement of World Health (Praeger/CBS Educational and Professional Publishers, 1985), and Heart Transplantation (MTP/Kluwer Academic Publishers, 1984). His most recent book is "Methods of Tissue Engineering" (Academic Press, 2001). Dr. Lanza received his B.A. and M.D. degrees from the University of Pennsylvania, where he was both a University Scholar and Benjamin Franklin Scholar.As a student, he studied in the laboratory of Richard Hynes (MIT), Jonas Salk (The Salk Institute), and Nobel laureates Gerald Edelman (Rockefeller University) and Rodney Porter (Oxford University). He also worked closely (and coauthored a series of papers) with the late Harvard Psychologist B.F. Skinner and heart transplant pioneer Christiaan Barnard.
Brigitte Boisselier
Clonaid chief executive Brigitte Boisselier
The privately held company, Clonaid, said a baby girl had been cloned through cells taken from a 31-year-old American woman. Clonaid director Brigitte Boisselier said the infant was born on December 26 at 11:55 a.m.